The Women’s Brain Foundation publication makes it to the cover of Nature Reviews Bioengineering

23 February 2026

We are proud to share that our work has been featured on the cover of Nature Reviews Bioengineering.


This recognition highlights a central message of our research:
Sex as a biological variable remains insufficiently integrated into neuroscience research — despite its major influence on disease mechanisms, therapeutic response, and translational outcomes.


Advancing neurological precision medicine requires:
• Systematic integration of sex differences in in vitro models
• Inclusion of sex-informed design in in vivo research
• Development of more accurate and reproducible translational tools

Precision medicine cannot be truly precise if biological sex is overlooked.

We sincerely thank the editorial and graphic teams, our collaborators, and our exceptional research team for their commitment and scientific rigor.

Under existing frameworks in Switzerland and Europe, our independent research structure is not yet eligible for direct access to public funding streams.


This creates a paradox:
High scientific impact — limited access to national funding mechanisms.
To continue advancing sex- and gender-informed neuroscience, we are actively seeking:
• Strategic institutional partnerships
• Philanthropic support
• Private and foundation-based collaborations


If your organisation believes in advancing rigorous, inclusive, and translational neuroscience, we invite you to connect with us.

Scientific progress depends not only on ideas — but on the structures that enable them. Independently.

Read the article

 

 

Explore all the benefits and find the right fit for you – Academy Membership

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.